The most useful 3D imaging breast implant planning evidence does not show that a computer can promise a finished breast. It shows something more practical: three-dimensional simulation, physical sizers and structured discussion can help a patient and surgeon describe the intended change, compare alternatives and identify where expectations do not fit the patient’s anatomy. They are communication and planning aids, not guarantees.
That distinction matters because breast augmentation is a preference-sensitive operation. A patient may want more upper-pole fullness, a softer slope, more projection in profile, a modest increase or better balance between the breasts. A surgeon must also consider breast-base width, chest-wall shape, skin quality, existing tissue, nipple and fold position, implant dimensions, pocket and long-term trade-offs. No single image or volume can represent all of those variables.
This evidence review concerns primary cosmetic breast augmentation unless a study is identified otherwise. Reconstruction, revision surgery, major ptosis and congenital chest-wall differences can involve different anatomy and goals. Results from one population should not be transferred automatically to another.
What shared decision-making means in implant planning
Shared decision-making is a clinical conversation in which the surgeon contributes medical knowledge and the patient contributes goals, preferences, concerns and tolerance for trade-offs. The choice is not made by a photograph, a software menu or a surgeon’s habit alone. It is built from the available evidence, the patient’s anatomy and the outcomes that matter to that person.
Decision aids can support this process. The NICE patient decision-aid standards describe tools that present options, benefits, harms and uncertainties in clear, balanced language and help people consider how their values affect a decision. The NICE shared decision-making guidance similarly frames care as a joint process based on evidence and the person’s preferences, beliefs and values.
The broader decision-aid literature supports better understanding more consistently than it supports a particular treatment choice. The updated Cochrane review of patient decision aids found improvements in knowledge, accuracy of risk perception and feeling informed or clear about personal values compared with usual care. It does not mean that every patient will become certain, choose surgery or have a better physical result. In elective implant planning, the aid should make the conversation more transparent, not make the decision for the patient.
In practice, a useful consultation may ask:
- What change does the patient want to see from the front, side and three-quarter views?
- Which features are priorities: width, projection, upper-pole fullness, softness, cleavage or a subtle change?
- Which trade-offs are acceptable if the first-choice implant is too wide, too projecting or poorly covered by the patient’s tissues?
- Is the patient open to a smaller implant, a different shape, another pocket, a lift, staged treatment or no operation?
- What risks, future monitoring and possible reoperation does the patient understand and accept?
These questions are more informative than asking a software program to find a single “perfect” size.
What 3D imaging can add
Three-dimensional imaging usually captures the external surface of the torso and breasts, then allows the clinician to overlay or simulate selected implant dimensions. Depending on the system, the consultation may compare volume, width, height, projection, implant shape or pocket. Some programs allow the patient to rotate the representation and view it from several angles.
This can improve the vocabulary of the consultation. “I want to look natural” is difficult to measure, whereas “I prefer less forward projection,” “I do not want the implant to extend too far laterally” or “I want more fullness above the nipple” gives the surgeon a more usable starting point. A patient may also discover that a preferred photograph reflects a different chest width, breast base, nipple position or amount of natural tissue and therefore cannot be reproduced simply by choosing the same nominal volume.
3D imaging can also help compare relative options. A simulation may show that increasing volume mainly increases projection, that a wider device distributes volume across the breast base, or that a proposed implant cannot fully correct a pre-existing asymmetry. Those comparisons are valuable even when the final shape differs from the image. They can expose an expectation mismatch before consent.
The technology is not the same as diagnostic imaging. Surface photography does not fully show the rib cage, muscle thickness, deep tissue planes or all of the structures that influence pocket creation. It also cannot know exactly how the surgeon will dissect, how the tissues will stretch, how swelling will resolve, how scars will mature or how the breast will change with time.
What the clinical studies show about 3D simulation
The early literature was encouraging but largely observational. Donfrancesco and colleagues studied 150 patients who underwent augmentation after consultation using three-dimensional simulation. At six months, patients generally viewed the technology favourably; in a separate retrospective comparison of 52 cases, an independent panel rated the overall similarity between simulations and postoperative breasts at an average of 7.5 on a 10-point scale. Eighty-six percent of patients considered the simulation very accurate. The study is useful evidence that patients value the visual aid, but the comparison sample was small, the design was not a controlled trial and perceived similarity is not the same as guaranteed prediction. Read the PubMed record for Donfrancesco et al.
The most informative prospective comparative study came from Overschmidt and colleagues. One hundred women were enrolled in a study with randomized and non-randomized components. In the randomized arm, 13 patients received tissue-based planning without simulation and 10 received simulation; many of the remaining participants specifically sought the technology and declined randomization. Breast augmentation improved satisfaction with breasts, sexual well-being and satisfaction with outcome over time. However, simulation did not produce a clinically meaningful difference in patient-reported outcomes or mammometric measurements. This is an important result: a tool may improve communication without independently changing the final outcome. Read the PubMed record for Overschmidt et al.
A prospective study of augmented-reality simulation using Arbrea software reported high patient satisfaction with the simulation and with the attained volume, with a mean simulation satisfaction score of 8.2 out of 10. The authors also cautioned that patients should not be promised absolute correspondence in breast shape between the simulation and postoperative result. Because it was a prospective study without the same kind of randomized comparison, its findings support acceptability and communication value more strongly than causal claims about surgical superiority. Read the PubMed record for La Padula et al.
The recent systematic review of preoperative three-dimensional simulation in aesthetic surgery identified 17 clinical studies, including 12 involving breast augmentation. It concluded that breast simulation is often reasonably accurate but that dissatisfaction and mismatches are not negligible, especially when anatomy, ptosis or implant positioning is more complex. Its central clinical message is consistent with the earlier studies: simulation is an approximation that can support planning, but reliance on it alone can create inaccuracies. Read the PubMed record for the 2026 systematic review.
A newer prospective Vectra study of 78 patients, representing 154 breasts, reported postoperative volume predictions within a plus-or-minus 10% threshold in 73% of cases and an average error of 7.52%. Accuracy varied with pregnancy history, starting breast volume and implant volume, and the nipple-to-inframammary-fold measurement showed more error than some other measurements. These results are useful because they quantify uncertainty rather than hiding it. They are not a universal accuracy rate for every camera, software system, surgeon, implant or body type. Read the PubMed record for the Vectra study.
Across these studies, the outcomes are also different. Some measure patient satisfaction with the simulation, some compare images with postoperative photographs, some measure volume or linear distances, and some use BREAST-Q outcomes. A high score in one domain does not prove accuracy in every domain. A simulation can approximate volume reasonably while missing breast shape, intermammary distance, fold behaviour or dynamic movement.
Where external and intraoperative sizers fit
External sizers are removable volumes placed in a bra or against the breast so that the patient can see and feel a relative change while standing, moving or wearing clothing. They are inexpensive, tactile and easy to compare. They can help translate a vague size request into a discussion of “more,” “less,” “too broad” or “too projecting.” They may be particularly useful when a patient finds images abstract or when the surgeon wants to compare options without implying that a cup letter is a reliable endpoint.
Their limitations are substantial. A bra sizer is not an implant. It does not have the exact shell, filler, base width, projection, surface or shape of the proposed device. It sits outside the skin rather than inside a surgically created pocket. It cannot reproduce muscle coverage, implant edge behaviour, the effect of the inframammary fold, tissue tension or postoperative swelling. Clothing, posture and the bra itself can also influence perception.
Intraoperative sizers or temporary implants are used after the pocket has been created, when the surgeon can assess how a candidate volume relates to the actual tissues. This provides information that a preoperative bra sizer cannot. Yet the patient is anaesthetised, the tissues are temporarily altered by dissection and swelling, and the final device still undergoes biological adaptation. Intraoperative assessment is therefore one part of surgical judgment, not a guarantee that the healed breast will match the operating-room appearance.
There is no universally accepted best sizing method. A survey of UK consultant plastic surgeons found that preoperative external sizers were the most common method reported: 74% of respondents used them, while 57% reported using measurements and 34% used a combination of measurements and sizers. The survey describes practice patterns, not comparative accuracy or superior patient outcomes, and its response rate was 46%. Read the PubMed record for Holmes et al.
The broader implant-selection evidence favours a tissue-based direction but remains limited. A 2016 systematic review identified 33 implant size-selection systems; only four articles reported clinical outcomes that could be compared with accepted literature values or industry standards. Tissue-based systems scored better for methodological quality than systems based mainly on patient or surgeon preference, but this does not establish one formula for every patient. Read the PubMed record for Adams and McKee.
The practical implication is not to reject sizers. It is to use them with measurements and a clear explanation of what they can and cannot demonstrate. A surgeon may compare the patient’s breast-base width, tissue coverage, skin envelope, fold and desired projection with the exact device dimensions. The patient can then decide which compromise is acceptable.
Why volume, shape and the final result are different things
Implant volume is normally expressed in cubic centimetres, but a number is not a bra cup and does not determine a breast shape. Two devices with similar volume can have different widths, heights and projections. A broader device can distribute volume across the chest with less forward extension; a narrower device can project further while covering less of the breast base. Neither is universally better.
The starting breast remains part of the result. Existing glandular tissue, skin thickness, stretch, chest contour, muscle coverage and nipple and fold position influence what the device looks like from the outside. Left and right sides may need different plans. A simulation may also smooth or standardise features that are difficult to change surgically, which can make the image appear more symmetrical or stable than the biological result will be.
This is why measurements and visual tools should be read together. The implant catalogue supplies exact device dimensions. Clinical examination assesses the tissue envelope. The patient explains preferences and priorities. A simulation or sizer makes the comparison easier to see. The final plan still depends on clinical judgment, consent and what is safe and realistic for that individual anatomy.
The limits of a visual promise
Patients should be told explicitly that a simulation is not a contract for a future photograph. Important sources of mismatch include:
- differences between the surface scan and the deep chest wall or muscle;
- pre-existing asymmetry, ptosis, tuberous shape or an unusual fold;
- the actual pocket, implant plane, incision and surgical technique;
- tissue elasticity, thickness, stretch and how the implant is covered;
- swelling, bruising, scar maturation and gradual settling;
- muscle contraction and movement, particularly when the implant is partly behind the pectoral muscle;
- weight change, pregnancy, ageing and future changes in the native breast;
- a patient’s interpretation of “natural,” “full,” “small” or “large.”
The 2026 review also notes that surface imaging cannot evaluate the thoracic wall in the same way as deeper imaging. This is especially relevant to marked asymmetry, chest-wall differences and complex revision planning. A more sophisticated display does not remove the need for examination, measurements or discussion of alternatives.
The same caution applies to before-and-after photographs. They can show the range of outcomes in a practice, but lighting, pose, clothing, camera angle, implant details and selection of images affect interpretation. Another patient’s photograph is a prompt for discussion, not a template for a promised result.
A patient-centred checklist for the consultation
Before consenting, a patient should be able to answer these questions in plain language:
- What exact implant options are being considered, including filler, shape, volume, width and projection?
- How do those dimensions relate to my breast base, chest wall and soft-tissue coverage?
- What does the 3D simulation or sizer show, and what important features can it not model?
- What would change if I chose a smaller, wider, narrower or more projecting implant?
- Is an implant alone realistic for my asymmetry, ptosis or tissue quality?
- What are the relevant risks, monitoring needs and possibilities of future surgery?
- Which option best fits my priorities, and what trade-off am I accepting?
If a patient is shown only one image and told it is the expected result, the tool is being used as a sales promise rather than as shared decision support. A better process presents reasonable alternatives, explains uncertainty and leaves time for questions.
Limitations of the evidence
The evidence base has important weaknesses. Studies use different software, cameras, implant types, measurement definitions, follow-up intervals and satisfaction scales. Many are single-centre cohorts or case series. Patients who choose simulation may be more engaged, have different expectations or be more willing to pay for technology than patients who do not choose it. That creates selection bias. In the randomized prospective study, many patients declined randomization, illustrating how difficult it is to separate the effect of the technology from the preferences of people who seek it.
Accuracy studies also do not always measure the same thing. Volume error, distance error, image similarity, patient satisfaction and postoperative BREAST-Q scores are related but not interchangeable. Most studies do not prove that a simulation lowers complications, prevents reoperation or produces a better long-term quality-of-life result. Evidence from breast reconstruction or other aesthetic operations can inform the principles of shared decision-making, but it should not be presented as direct evidence for primary cosmetic augmentation.
Conclusion
The best-supported interpretation of 3D imaging breast implant planning evidence is modest and useful. Three-dimensional simulation can make options easier to see and discuss. External and intraoperative sizers add tactile or pocket-specific information. Measurements help relate the proposed device to the patient’s tissues. Decision aids can improve knowledge, clarify values and reduce the feeling of being uninformed.
None of these tools can guarantee a cup size, exact symmetry, a specific cleavage pattern or a final photograph. The responsible plan is the one that combines the patient’s goals with examination, tissue-based measurements, exact implant dimensions, surgeon judgment, balanced risk communication and acceptance of uncertainty. The image is a conversation starter; it is not the outcome itself.
For a shorter patient-oriented explanation, see the Breast Implant Dimensions: Width, Base and Volume in CC guide and Breast Implant Profile and Projection Explained. For the broader procedure, see the breast augmentation operation guide. These pages provide practical context; they do not replace an individual consultation.
Frequently asked questions
Is 3D imaging accurate for breast implant planning?
It can be reasonably useful for comparing relative volume and contour, but accuracy varies by software, anatomy, implant and measurement. Studies report mismatches and do not support treating a simulation as a guaranteed final result. It should complement examination and implant-specific planning.
Does 3D simulation improve breast augmentation results?
A prospective comparative study found that augmentation improved patient-reported outcomes, but adding simulation did not create a clinically meaningful difference in those outcomes or mammometric measurements. Simulation may improve communication without independently changing the surgical result.
Are breast implant sizers reliable?
External sizers are useful for communicating relative size and projection, but they are not the same as an implant inside a surgical pocket. Intraoperative sizers provide additional information after pocket creation, yet swelling and later tissue adaptation mean that neither type guarantees the healed appearance.
Can a sizer or 3D image tell me my future bra cup size?
No. Cup letters vary between brands and band sizes, and breast appearance depends on chest width, starting tissue, implant dimensions, pocket, healing and clothing. A sizer or simulation can help express a preference, but it cannot promise a cup size.
What should I ask about a proposed implant plan?
Ask for the exact device dimensions, including volume, width and projection, and ask how they fit your breast base and tissue coverage. Ask what the simulation does not show, what alternatives exist, and which risks or future procedures are relevant to your choice.
Is shared decision-making the same as letting the patient choose any implant?
No. It means combining the patient’s informed goals and values with clinical assessment, evidence and professional judgment. A surgeon should explain when a requested size or shape is a poor match for the tissues and should discuss safer or more realistic alternatives.
Can 3D imaging correct breast asymmetry?
It can help show the degree and direction of asymmetry and compare possible plans. It cannot make the two sides biologically identical or guarantee perfect symmetry. Different implant volumes, fold adjustments, a lift, staged treatment or acceptance of residual difference may need discussion.
Limitations and medical disclaimer
This article is an evidence review for education, not a diagnosis or personal treatment recommendation. The cited studies include primary cosmetic augmentation cohorts, technology-specific evaluations and broader decision-aid evidence; they should not be treated as interchangeable. A qualified plastic surgeon must assess the patient’s anatomy, health, goals, implant information and follow-up needs. Technology availability and device labeling can vary by country and may change.
Visible sources and references
- NICE — Patient decision aids and shared decision-making support.
- NICE — Content and process standards for patient decision aids.
- Cochrane — Decision aids for people facing health treatment or screening decisions.
- Williams DC, Seifman MA, Hunter-Smith DJ. Patient related outcome measures for breast augmentation mammoplasty. Gland Surgery. 2019. DOI: 10.21037/gs.2019.03.10.
- Knoedler S, et al. Quality of life and satisfaction after breast augmentation. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2024. DOI: 10.1016/j.bjps.2024.06.016.
- Donfrancesco A, Montemurro P, Hedén P. Three-dimensional simulated images in breast augmentation surgery. Plastic and Reconstructive Surgery. 2013. DOI: 10.1097/PRS.0b013e3182a014cb.
- Overschmidt B, et al. A Prospective Evaluation of Three-Dimensional Image Simulation. Plastic and Reconstructive Surgery. 2018. DOI: 10.1097/PRS.0000000000004601.
- La Padula S, et al. Assessment of Patient Satisfaction Using a New Augmented Reality Simulation Software. Journal of Clinical Medicine. 2022. DOI: 10.3390/jcm11123464.
- Preoperative 3-dimensional Simulation in Aesthetic Surgery. Plastic and Reconstructive Surgery Global Open. 2026. DOI: 10.1097/GOX.0000000000007999.
- 3-Dimensional Simulation for Breast Augmentation: Does the Software Actually Work?. Aesthetic Surgery Journal. 2026.
- Holmes WJ, et al. Techniques used by United Kingdom consultant plastic surgeons to select implant size. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2015. DOI: 10.1016/j.bjps.2015.06.002.
- Adams WP Jr, McKee D. Matching the Implant to the Breast. Plastic and Reconstructive Surgery. 2016. DOI: 10.1097/PRS.0000000000002623.
- Perry D, Frame JD. The history and development of breast implants. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2020. Starting plan source S33; used for the distinction between implant development, cosmetic augmentation and reconstruction.
- ERAS Society — Breast surgery recommendations. Starting plan source S34; perioperative guidance is outside this article’s substantive scope.
Internal-link proposals for later reciprocal integration
These proposals are recorded for the lead agent because this task is restricted to Academic #22 files. No existing seeder or shared architecture has been edited.
- Link to implant profile and projection evidence using descriptive anchor text, with a reciprocal link during the academic batch.
- Link to implant dimensions, base width and cc evidence using descriptive anchor text, with a reciprocal link during the academic batch.
- Link to round versus anatomical implant evidence when discussing device shape.
- Link to the breast augmentation operation guide for procedural context, without presenting it as evidence.
- Link to the practical implant dimensions, profile and projection and body proportions guides for plain-language companion reading.
- Add a limited contextual link to the breast augmentation all-inclusive package only when the coordinated batch adds a patient next-step section; it must not dominate the evidence article.
Author: BreastAugmentationInTurkey.org Editorial Team
Medical reviewer: Qualified plastic surgeon — to be confirmed before publication
Published: 11 September 2026
Evidence updated / medically reviewed: 11 September 2026